ACOXL: A Protein with Diverse Functions and Potential as A Drug Target

Target Name: ACOXL

NCBI ID: G55289

ACOXL

ACOXL: A Protein with Diverse Functions and Potential as A Drug Target

ACOXL (short for ACOXL variant 1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells.

One of the unique features of ACOXL is its ability to interact with a variety of different molecules, including transcription factors, DNA replicators, and signaling proteins. This makes it an attractive target for researchers who are interested in understanding the role of these molecules in various biological processes.

In addition to its potential as a drug target, ACOXL is also a potential biomarker for a variety of diseases. For example, some studies have suggested that high levels of ACOXL may be associated with an increased risk of certain types of cancer, including breast and ovarian cancer.

Other research has also suggested that ACOXL may be involved in a variety of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. In these cases, ACOXL has been shown to be expressed at higher levels in the brains of individuals with these conditions, and may be involved in the progression of these diseases.

While more research is needed to fully understand the role of ACOXL in these biological processes, it is clear that this protein is of great interest to researchers who are studying the underlying mechanisms of various diseases. As such, ACOXL is a promising target for future drug development and research into the biology of disease.

Protein Name: Acyl-CoA Oxidase Like

The "ACOXL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ACOXL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets